Final Agenda Now Available

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than 1,100 delegates from 36 countries, including 70% from pharma and biotech organizations, convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. The 2019 event will feature:

  • 1,300 attendees
  • 260 speakers
  • 18 keynote presentations
  • 55 presentations from Top Biopharma
  • 25 problem-solving breakout discussions
  • 250 scientific posters
  • 100+ industry-leading sponsors & exhibitors
  • Dedicated networking opportunities
  • Exclusive exhibit & poster viewing hours

Short Courses

Make the most of your time in Lisbon! Maximize your educational and networking opportunities by adding on one or more interactive, hands-on short courses. Covering some of the hottest topics in the field, these short courses are taught by leading researchers from industry and academia.

Training Seminars by Cambridge Healthtech Institute

Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered and solutions applied, and extensive coverage of the basic science underlying each topic. Experienced Training Seminar instructors offer a mix of formal lectures, interactive discussions and activities to help attendees maximize their learning experiences. These immersive trainings will be of value to scientists from industry and academic research groups who are entering new fields – and to those working in supporting roles that will benefit from an in-depth briefing on a specific aspect of the industry.

2019 Plenary Keynotes

Bahija Jallal, PhD, CEO and Director of the Board, ImmunocoreBispecific, Soluble TCR as the Next Therapeutic Platform
Bahija Jallal, PhD, CEO and Director of the Board, Immunocore
James A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San FranciscoAttacking Cancer Cell Surfaceomes with Recombinant Antibodies
James A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco

Colleague Testimonials

“The best biologics technology meeting in Europe: a must-attend conference for novel biologics.”
- Rakesh D., PhD, VP, AstraZeneca

“I was very much impressed by the quality of the event, the depth and breadth of the presentations, as well as the scientific discussions and excitement. This is the event to participate and enjoy.”
- Yan Q., PhD, Senior Principal Scientist, Rinat Pfizer

"The best protein engineering conference in Europe! The breadth of topics was truly impressive, with excellent talks, discussions as well as networking on everything from details of sophisticated protein engineering to updates on recent clinical studies of new biologics. A must go!”
- John L., PhD, Associate Professor, KTH Royal Institute of Technology

“Once more PEGS Europe was a great event, packed with know-how knowledge, and networking at its best.”
- Philipp M., PhD, Principal Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG

“You really have the ability to put together diverse and interesting speakers together with real data – not just sales pitch data! I hope all enjoyed as much as I did.”
- Denise F., MD, PhD, Director, Massachusetts General Hospital, and Associate Professor, Harvard Medical School

“PEGS Europe is the place to be for everyone working on antibodies and next generation biologics.”
- Martin B., PhD, Head, Biochemical and Analytical Research, Roche

Read More Testimonials